Laroxtipene Tablet (Laroxtipene Hydrochloride)

Adult dose

Administer 60 mg orally once daily as Laroxtipene Hydrochloride.

This drug is used for the treatment and prevention of osteoporosis in postmenopausal women. Care should be taken when taking this medication, as the risk of thrombosis, particularly venous thromboembolism, may increase. If you experience restricted movement, you should stop taking the medication and may restart once your condition has improved. Patients with liver function issues may have elevated blood levels of this drug, so regular liver function tests should be conducted, and it should be administered with caution. This medication is not for use in premenopausal women and should not be given to pregnant or potentially pregnant women or nursing mothers, as it may harm the fetus or nursing infant. Patients with a history of cardiovascular disease or stroke may face increased risks when taking this medication, so they should use it cautiously after consulting with a physician. This drug should not be used for the prevention of cardiovascular disease and is not recommended to be used in conjunction with other estrogen preparations. Possible side effects during the use of this medication include thrombosis, leg cramps, cold symptoms, peripheral edema, facial flushing, etc. If side effects are severe or if abnormal symptoms occur, immediate consultation with medical staff is necessary. This medication should not be used in patients with certain genetic metabolic disorders, liver impairment, or unexplained uterine bleeding. When used in conjunction with other medications, it may affect the concentration of some drugs, so inform medical staff of any concurrent medications being taken. This medication is only for use in postmenopausal women and should not be given to men or children. In case of overdose, symptoms such as leg cramps and dizziness may occur, and there is no specific antidote, so immediate visit to a medical facility is required. This medication should be kept out of reach of children and should not be transferred to another container.

Serious side effects

• Deep vein thrombosis
• pulmonary embolism
• retinal vein thrombosis
• superficial venous thrombophlebitis
• venous thromboembolism
• arterial thrombosis
• retinal vein occlusion
• stroke
• death related to deep vein thrombosis
• thrombocytopenia

Mild side effects

Vasodilation (flushing), leg cramps, cold symptoms, peripheral edema, nausea, vomiting, abdominal pain, indigestion, elevated blood pressure, migraine, rash, breast symptoms (pain, swelling, tenderness), vaginal bleeding, facial swelling, heartburn, constipation, itching, palpitations, fever, weakness, sweating, muscle pain, insomnia, perineal pain, weight gain, arthritis, rheumatic-like symptoms, pain, fatigue, discomfort, chest discomfort, skin lesions, anxiety, weight loss,

This medication should be stored in a sealed container to keep air out, and it is best kept in a cool place between 15 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer period.

Appearance

White oval film-coated tablet

Package unit

28 tablets (14 tablets/PTP package x 2)